semaglutide mash Significantly Improves Steatohepatitis, Fibrosis in Phase III Trial A new systematic review just

GLP-1s Dont Have To Be Permanent

On the other hand, although statistical significance was not reached, the use of GLP-1RAs showed a trend towards a reduced risk of nine respiratory diseases (pneumonia, pulmonary fibrosis, dyspnea, acute respiratory failure, pleural effusion, COPD, sleep apnea syndrome, and pulmonary embolism)

Association between colonic 18 F-FDG uptake and glycemic control in patients with diabetes mellitus

And in the extension phase out to 104 weeks, the highest dose arm exceeded 30% weight reduction

doi: 10.1016/j.mam.2021.101026 34

Semaglutide may have particular benefits when used in patients with T2DM who are overweight